Lyme Disease Vaccine

May 31, 2018

In 2017, a report released by Public Health England showed that diagnosed cases of Lyme disease were on the rise.

This year, biotech company Valneva has reported successful phase 1 studies of a Lyme disease vaccine. Initial data has shown the vaccine has the potential to provide a high level of protection against the six most prevalent types of Lyme disease in humans.

Learn more about Lyme disease, its clinical symptoms, and epidemiology with our factsheet – including free chapters from a variety of titles on infectious disease.